Sign Up
bg
A

Allogene (ALLO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allogene (ALLO)

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more

  • USD1.24
  • USD1.31
  • USD1.21
  • USD3.78
  • -1.60%
  • --
  • 3.62M
  • 3.16M
  • 266M
  • 0.86
  • -49.60%

Stock News